| General Information of This Metabolic Reaction (MR) (ID:
MR000911) |
| Formula |
|
| Reactant |
Epoprostenol |
Product |
6,15-Diketo-13,14-dihydro-PGF1alpha |
|
Reactant Info
|
Product Info
|
|
Metabolic Type
|
Oxidation
-
Hydroxylation
|
|
|
|
|
|
|
|
| Other MR(s) Related to The Reactant of This MR |
|
Other MR(s) That Metabolize The Reactant of This MR
|
|
|
| References |
| 1 |
Integrated pharmacokinetics and pharmacodynamics of epoprostenol in healthy subjects Br J Clin Pharmacol. 2012 Dec;74(6):978-89. doi: 10.1111/j.1365-2125.2012.04301.x.
|
| 2 |
In search of pulmonary hypertension treatments: Effect of 17-estradiol on PGI(2) pathway in human pulmonary artery. Prostaglandins Leukot Essent Fatty Acids. 2021 Sep;172:102321. doi: 10.1016/j.plefa.2021.102321.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.